OpenSIMPLe: A real-world implementation feasibility study of a smartphone-based psychoeducation programme for bipolar disorder by Hidalgo-Mazzei, Diego et al.
 Accepted Manuscript
OpenSIMPLe: A real-world implementation feasibility study of a
smartphone-based psychoeducation programme for bipolar disorder
Diego Hidalgo-Mazzei , Marı´a Reinares , Ainoa Mateu ,
Viktoriya L Nikolova , Caterina del Mar Bonnı´n , Ludovic Samalin ,
Aitana Garcı´a-Estela , Vı´ctor Pe´rez-Sola´ , Allan H. Young ,
Sergio Strejilevich , Eduard Vieta , Francesc Colom
PII: S0165-0327(18)30848-6
DOI: https://doi.org/10.1016/j.jad.2018.08.048
Reference: JAD 10046
To appear in: Journal of Affective Disorders
Received date: 20 April 2018
Revised date: 19 July 2018
Accepted date: 12 August 2018
Please cite this article as: Diego Hidalgo-Mazzei , Marı´a Reinares , Ainoa Mateu ,
Viktoriya L Nikolova , Caterina del Mar Bonnı´n , Ludovic Samalin , Aitana Garcı´a-Estela ,
Vı´ctor Pe´rez-Sola´ , Allan H. Young , Sergio Strejilevich , Eduard Vieta , Francesc Colom ,
OpenSIMPLe: A real-world implementation feasibility study of a smartphone-based psy-
choeducation programme for bipolar disorder, Journal of Affective Disorders (2018), doi:
https://doi.org/10.1016/j.jad.2018.08.048
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service
to our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and
all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Highlights 
 So far, many mental health internet-based platforms(IBP) were developed and tested. 
 Few of these IBPs were made widely available for mental health patients. 
 OpenSIMPLe evaluated the large-scale implementation of an IBP for bipolar disorder. 
 Positive outcomes regarding satisfaction, usability and helpfulness were found. 
 Attrition rates were high, requiring further research about retention factors.  
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Abstract 
Background: Few evidence-based mental health apps are widely available to patients and, 
conversely, many of the available apps haven´t been appropriately evaluated. Given that the 
ultimate goal is to scale-up and open Internet-based platforms (IBP), it is crucial to appropriately 
evaluate their real-world feasibility beforehand. We aimed to evaluate the implementation 
feasibility of a smartphone-based psychoeducational programme for bipolar disorder, exploring its 
long-term retention, usability, perceived helpfulness and satisfaction, alongside its impact on 
secondary health outcomes.   
Methods: Participants were recruited via the project website after completing an online screening 
questionnaire. They were requested to complete web-based questionnaires before using the app 
and after 6 months of use which included sociodemographic, illness and treatment variables, the 
World Health Organisation-Five Well-Being Index (WHO-5) and the Short Form Health Survey (SF-
36). The follow-up questionnaires also contained satisfaction and usefulness questions.  
Results: 201 participants took part in the study. According to their retention, 66.2% of the 
participants were classified as non-completers and 33.8% as completers. The only predictor 
significantly associated with higher odds of retention was older age (OR=1.021, p <0.001). 62% of the 
users reported they were satisfied with the programme with a higher percentage among completers. 
WHO-5 baseline and follow-up scores showed a significant improvement as well as 6 out of 8 
domains of the SF-36.  
Limitations: Screening and outcome measures were administered using exclusively self-reported 
online methods. 
Conclusion: The 6-month attrition rate of the programme was high. Positive outcomes regarding 
satisfaction were found predominantly among completers. The optimal dosage and retention of IBP 
mental health programmes remain challenging issues that need further research. 
Keywords: Smartphones; bipolar disorder; psychoeducation; SIMPLe; mental health; 
implementation. 
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Introduction 
 
The high prevalence of mental health disorders in comparison to the limited availability of traditional 
healthcare resources has led to an increasing interest in new cost-effective methods which could 
meet this growing demand and burden (Kessler et al., 2007; Whiteford et al., 2013). Given their 
growing, ubiquitous and broad accessibility, Internet-based platforms (IBP) have frequently been 
proposed as a potential solution for reaching wider populations and increasing large-scale 
availability of health services, while simultaneously reducing costs. Thus, over the last twenty years, 
several projects have explored the possibility of providing adjunctive interventions through a wide 
array of e-mental health approaches for the most prevalent mental disorders (Lal and Adair, 2014).  
 
Despite the initial optimism around IBPs in the mental health field and some positive findings 
regarding their efficacy, few projects have successfully implemented the platforms they evaluated 
(Buntrock et al., 2016; Firth et al., 2017; Wozney et al., 2017a).  Most remained as research-only 
platforms never accomplishing their ultimate aim of becoming mental healthcare services in the real 
world (Meurk et al., 2016; Wozney et al., 2017a). Conversely, many platforms and smartphone 
applications (apps) which were not properly evaluated ended up being widely available mainly due 
to an increasing pressure of stakeholders (Ruwaard and Kok, 2015) and the lack of clear validation 
guidelines and policies to regulate these new technologies (Charani et al., 2014; Lewis and Wyatt, 
2014; Torous et al., 2016). In fact, few of the currently available e-mental health apps provide 
contents in accordance with established self-management or practice guidelines standards (Bakker 
et al., 2016; Nicholas et al., 2015).      
 
Among the most prevalent of mental health disorders, Bipolar disorder (BD) is a chronic, recurrent 
and disabling condition affecting more than 2% of the world population (Merikangas et al., 2011; 
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Whiteford et al., 2013). It consists of acute episodes of mood fluctuations and long-term sub-
syndromal symptoms which have a significant negative impact on patients´ quality of life, cognition, 
and life expectancy (Martínez-Arán et al., 2004; Michalak et al., 2005). In this context, SIMPLe (Self-
monitoring and psychoeducation in patients with BD with a smartphone application) is a non-
commercial academic project set out to develop and validate several IBPs and, amongst them, a self-
management smartphone app for patients with BD. The app collects continuous information about 
symptomatology while offering personalized psychoeducation messages as an addition to treatment 
as usual in order to prevent relapses (Hidalgo-Mazzei et al., 2015). The psychoeducational contents 
are based on a face-to-face group psychological programme developed and extensively evaluated by 
our group (Colom et al., 2009; Colom and Vieta, 2006). It is worth mentioning that both efficacy and 
cost-effectiveness results were positive and the programme showed a significant reduction of the 
number of episodes to a half in the 5 years follow-up as well as improving other relevant clinical 
outcomes in BD (Colom et al., 2009). Unfortunately, despite being recommended as a first-line 
psychological treatment for maintenance in most international guidelines, the program did not make 
it in terms of implementation and dissemination. Hence, the ultimate goal of the SIMPLe project is to 
extend, personalize and facilitate the wide access to the psychoeducational contents of the 
programme around the world to everyone who may need it.     
 
 The early feasibility, acceptability, safety and user satisfaction of the first version of the app (SIMPLe 
1.0) was evaluated in a 3-month study involving more than 50 patients with BD and showed positive 
and encouraging results (Hidalgo-Mazzei et al., 2016). Moreover, post hoc analyses also suggested 
some potential improvements in terms of the biological rhythms of the patients and medication 
adherence (Hidalgo-Mazzei et al., 2017).  An independent and parallel randomized clinical trial (RCT) 
evaluating the efficacy of the second version of the app (SIMPLe+) is currently ongoing.  
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However, as is the case with other e-mental health interventions, one of the main issues noted 
during the feasibility study was the retention of participants (Ben-Zeev et al., 2016; Hidalgo-Mazzei 
et al., 2016).  Although an acceptable 74% retention rate was attained at 3 months, the contents of 
our programme are intended to be delivered across a 6 months period. Therefore, the final 
implementation of a potentially widely available intervention could have been compromised if 
retention continued to drop. Moreover, upscaling of an open platform could potentially be affected 
by socio-demographic, cultural and technical factors (Aranda-Jan et al., 2014; Wozney et al., 2017b).    
 
Considering the results of our initial feasibility study, the educational nature of the platform and 
requests from patients’ associations and other Institutions to use an improved, modified and open 
version of the SIMPLe original app (i.e. SIMPLE 1.5) we decided to open the app to a wider 
population whilst remaining within an independent and parallel research protocol until conclusive 
results regarding its efficacy are available.  
 
OpenSIMPLe is thus an implementation feasibility study using SIMPLe 1.5 aimed at evaluating the 
long-term retention, usability, perceived helpfulness and satisfaction among the first 201 users of 
the programme: a wider and more diverse population of patients with BD.  Simultaneously, we set 
out to explore sociodemographic, self-reported clinical factors and technical factors influencing 
retention, while testing the system’s capability in handling a larger number of users. Moreover, we 
explored secondary clinical outcomes related to general health and well-being among the app users.  
 
Methods 
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The intervention: SIMPLe 1.5 
The application offered to the participants in this study was an improved version of SIMPLe 1.0 
(Hidalgo-Mazzei et al., 2016). Following the user-centred design approach adopted by the project 
(Hidalgo-Mazzei et al., 2015; McCurdie et al., 2012; Roth et al., 2014), in SIMPLe 1.5 we incorporated 
suggestions based on feedback received by patients during the feasibility study as well as 
modifications to adapt the platform for an open study. Additionally, we developed an iOS version 
with the same characteristics, which was not previously available.  
 
In brief, the basic functionality of the app was similar to the first version. It consisted of a daily short 
graphic 5-item (mood, energy, sleep time, medication adherence and irritability) screening test and a 
weekly, more comprehensive YES or NO test, considering all DSM-5 criteria for manic and depressive 
episodes, including suicidal thoughts. Based on the information collected, a daily pop-up notification 
prompted the user to read a short psychoeducational message providing brief information or advice 
about how to deal with specific situations in order to avoid relapses. Each message was originally 
extracted from a library of more than 500 messages categorized according to different clinical 
situations based on published psychoeducational manuals for BD (Colom and Vieta, 2006). The 
educational messages were short and used plain language in order to ensure readability. A detailed 
description of the SIMPLe 1.0 app has previously been provided elsewhere (Hidalgo-Mazzei et al., 
2016).  
 
In addition to these functions, new features and characteristics were incorporated in SIMPLe 1.5 
while at the same time it was stripped down from the main interventional components as follows:  
- Medication reminders: The users could activate this module and choose from a list the 
medications they were taking and the time schedule. A pop-up notification prompted them 
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at the specified time to indicate whether they had taken their medication or not. Based on 
their answers a medication adherence score was calculated and, thus, the adherence 
question was omitted from the daily test. If the module was not activated, the medication 
adherence question remained in the daily test.  
 
- Personalized prodromal symptoms: If this module was activated, after a brief tutorial to 
identify previous prodromal symptoms, the users could register their own past prodromal 
symptoms for each kind of episode. These were then added as an additional question in the 
weekly test. 
 
- Gamification module: A basic virtual reward gamification module was implemented to 
encourage the engagement with the app. Depending on the number of tests completed and 
psychoeducational messages read each week, the users were awarded different medals (e.g. 
gold, silver, bronze, etc) and motivational messages. They could view the accumulated 
medals in a trophy gallery.  
 
- Mood-chart sharing: Users could share their mood-chart graphic (not containing identifiable 
information) through e-mail. 
 
- Psychoeducational messages community: The users could create and share anonymously 
their own advice and psychoeducational messages with the rest of the community. The 
messages were reviewed by mental health professionals (DH, FC), screened and cleaned 
from any potentially identifiable information, and added to the library in the correct 
category.  The main aim of this feature was to replicate the sense of community and mutual 
collaboration of the face-to-face psychoeducational groups.  
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In order to comply with legal and ethical requirements as well as to moderate the interventional 
functions, the users were offered to configure their local emergency services telephone number and 
a reference e-mail of their preference. In the previous version these functions were not optional but 
instead linked to our clinic e-mail and local emergency services.  Furthermore, although the initial 
versions of the app’s mood scores showed acceptable correlations with the Young Mania Rating 
Scale (YMRS) and the 17-item Hamilton Depression Rating Scale (HDRS)(Hidalgo-Mazzei et al., 2016), 
minor improvements were made to the mood score calculation algorithm and redesigning the 
home-screen menu. Android and iOS versions were available only in Spanish.  
 
Procedure and participants 
The option to participate in the study was available on the project website 
(www.simplebipolarproject.org). No active online or direct advertisements were made by the 
researchers, except for leaflets explaining the study available at our bipolar disorders reference 
centre in Hospital Clinic and Hospital del Mar (Barcelona) and at Favaloro´s Hospital Bipolar Disorder 
Programme clinic in Buenos Aires, Argentina. Patient associations’ representatives who had 
contacted the team for the previous project were also notified of the availability of the study. The 
study included participants enrolled from May 2016 to August 2017.  
 
The project’s website contained information detailing the study purpose and eligibility criteria. 
Potential participants were requested to read and accept the conditions of participation in an 
informed consent (i.e. be ≥ 18 years, previously diagnosed with BD by a mental health professional, 
receiving direct and routine pharmacological treatment for their condition by a psychiatrist, 
currently owning and using daily an Android or iOS compatible smartphone, fully fluent in Spanish, 
with an active e-mail account and to complete a screening questionnaire). If they did not accept the 
conditions they were asked to state the main reason for declining participation. If they accepted, 
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potential participants were asked to complete a modified version of the Mood disorder 
questionnaire (MDQ)(Hirschfeld, 2002; Vieta et al., 2007). Based on their answers and using the 
same cut-off of the original MDQ, participants were informed whether they met the eligibility 
criteria for the study. We blocked the possibility to complete the questionnaire multiple times from 
the same IP address to prevent duplicate users and potential misuse.  
 
Assessments and measures 
Following consent, participants were requested to fill out an online form containing: 
sociodemographic questions, illness and treatment history, the World Health Organisation-Five Well-
Being Index (WHO-5) (Bonnín et al., 2018; World Health Organization, 2004) and the Short Form 
Health Survey (SF-36)(Turner-Bowker et al., 2012; Vilagut et al., 2005). After completing this 
information, participants were asked to provide a contact e-mail address. The responses were 
reviewed by a psychiatrist for consistency and within 72 hours an e-mail containing their personal 
six-digit alphanumerical access credentials was sent alongside instructions of how to download the 
app and log in.  After 6 months of their inclusion in the programme, participants were prompted 
with an e-mail to complete a follow-up online questionnaire containing the WHO-5, SF-36, number 
of hospitalisations, suicide attempts and treatment history during the past 6 months. Episode 
density was calculated dividing the total number of previous episodes by the length of illness. 
The retention, use, engagement and subjective mood reported were collected from the data stored 
in the cloud server during the duration of the study. The engagement was calculated based on the 
weekly percentage of completed tasks (i.e. answering daily and weekly tests and reading the daily 
psychoeducational messages). Additionally, the follow-up questionnaire contained the system 
usability scale (SUS)(Brooke, 1996) as well as satisfaction and perceived helpfulness Likert scales.  
Technical support was provided to the users via e-mail throughout the duration of the study. 
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However, it was made clear that no advice regarding clinical status or treatment would be offered 
and this should be sought from their psychiatrist/psychologist.  
 
The study was approved by the Ethical committees of the Hospital Clínic of Barcelona 
(HCB/2016/0403) and the Hospital del Mar - IMIM: Institut Hospital del Mar d'Investigacions 
Mèdiques (2016/6764/I).  
 
Data analyses 
Descriptive analyses were conducted to characterize the sociodemographic and clinical 
characteristics of the initial sample as well as retention at the end of the programme, satisfaction 
and perceived helpfulness of each subcomponent of the app. Participants were further classified 
according to the total duration of app use as either non-completers (≤4.99 months of use) and 
completers (≥5 months of use). The lower-threshold for month usage was of at least 5 daily tests and 
2 weekly tests completed within a month.  This cut-off was set keeping in mind that, above 5 
months, approximately 85% of the programme’s essential contents would have been delivered 
which could be considered sufficient to enhance an initial therapeutic effect. Sociodemographic, 
clinical and treatment variables that could possibly affect retention were explored, performing Zero-
Inflated Negative Binomial Regression analyses. An assessment of normality was performed to 
determine the distribution of the variables implicated in all analyses. Accordingly, non-parametric 
analyses were employed to compare the sample baseline and follow-up domains and total scores of 
the SF-36 and WHO-5, respectively, as well as suicide attempts and hospitalizations. Potential pre-
post differences of these variables between completer and non-completers were also explored. 
Statistical significance was established at p = <.05 level. All analyses were two-tailed and carried out 
using SPSS version 24.0 and zeroinfl R package.  
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Results 
Figure 1 detail the number of potential participants initially interested through to those included in 
and completing the project.   
[Figure 1 goes here] 
Sociodemographic and clinical characteristics 
After the screening process, two hundred and one subjects were included in the study. There was a 
preponderance of users from Spain (N=85), followed by Argentina (N=41), Chile (N=22) and Mexico 
(N=12). The mean age was 36.59 (SD=11) with a majority of female users (N=127, 63.2%) from a 
Latin-American origin (N=121, 60.5%) and with high education levels (N=126, 62.7%).  A high 
percentage of the sample was actively employed at the time of the study entry (N=84, 41.8%) while 
only 20.9% were either in temporal (N=20) or permanent leave (N=22).  Regarding housing 
conditions, more than half of the sample reported leaving independently, either owning (35.3%) or 
renting their current home (17.4%). Further sociodemographic variables of the sample are described 
in Table 1.  
[Table 1 goes here] 
Regarding the clinical characteristics, the sample reported a mean of 7.9 (SD=8.1) illness years, a 
significant number of previous manic/hypomanic (N=6.9, SD=3.3) and depressive episodes (N=6.2, 
SD=3.6), with a mean episode density of 0.8 (SD=1.9). Participants reported a high prevalence of 
both psychiatric and non-psychiatric comorbidities (N=123, 61.2%). Most of the subjects included 
were receiving treatment with at least one mood stabilizer (N=156, 77.6%) and at least one 
antipsychotic (N=129, 64.1%), while almost half of the sample was receiving at least one 
antidepressant (N=98, 48.7%). Further, 71% of the sample was receiving some kind of face-to-face 
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psychological treatment. More details about the clinical characteristics and treatments collected at 
baseline are described in Table 2. 
[Table 2 goes here] 
Retention, use and engagement  
The overall sample used the app for a median of 2 months (IQR 7). Thirty per cent (N=61) of the 
initial users remained interacting regularly with the app after 6 months. The attrition rate was 23.3 
users per month. The highest number of drop-outs was observed during the first month when 
almost one-third (N=70, 34.8%) of users dropped out (Figure 2).  
[Figure 2 goes here] 
According to their retention, 133 (66.2%) patients were classified as non-completers and 68 (33.8%) 
as completers. A zero-inflated negative binomial logistic regression was performed to ascertain 
separately the effects of sociodemographic, clinical variables and treatment on participant retention. 
Among the sociodemographic variables, the only predictor significantly increasing the odds of 
retention was an increased age (OR=1.021, Coefficient=0.021, SE=0.00613, z=3.47, p <0.001, CI 95% 
= 0.0092-0.033). None of the clinical or treatment variables was found to have influenced long-term 
retention in the programme.  
 
The overall average daily interaction of users while using the app was 1.8 times per day (SD=3.2). 
The average weekly engagement with the app of completers was as follows: 50 (25%) participants 
completed all tasks, 32 (16%) completed three-quarters, 30 (15%) completed half and 89 (44%) 
completed less than 25% of the tasks required. The average mood score reported by the participants 
during the study was -2.35 (SD=6.39), denoting based on our previous correlation with the HDRS and 
YMRS, a tendency to a slightly depressive mood. A detailed explanation of how these mood scores 
are calculated is provided in a previous study (Hidalgo-Mazzei et al., 2016). Only 72 (35.8%) of the 
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users activated the medication reminders module. 72 psychoeducational messages from the users 
were received, reviewed, adapted and added to the psychoeducational messages library. 
 
Usability, satisfaction and perceived helpfulness 
One hundred and three participants (51.2%) responded to the follow-up questionnaire after 6 
months of initiating the programme, of which fifty-six (54.4%) were non-completers. As per the 
usability, the mean SUS score of users who completed the follow-up questionnaire was of 77.23 
(SD=16.7).  An independent samples t-test showed that this score was significantly lower among 
non-completers (t (101) = -2.65, p= 0.09).  
 
Regarding the overall satisfaction of those who completed the follow-up questionnaire, 62% 
reported that they were either very satisfied or satisfied with the general experience of using the 
app with a significantly higher proportion among completers (X2 = 5.58, p <0.01).  Seventy percent 
strongly agreed or agreed that the app was easy to use. Likewise, almost the same percentage was 
reported regarding its daily use discretion and quickness, with 70% and 74%, respectively, strongly 
agreeing or agreeing about these aspects. No significant differences were found among the 
aforementioned variables between completers and non-completers. 
 
In the follow-up questionnaire, we explored not only the general perceived helpfulness, but also 
which components of the app were considered by users to be most helpful in the self-management 
of their disorder. Users agreed that the most useful features were the mood chart, 
psychoeducational messages and daily tests, while the least useful were the gamification module, 
medication reminder, prodromal symptoms and mood chart sharing modules (Figure 3). 
  [Figure 3 goes here] 
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The most common reasons stated by participants for discontinuing app use were: repetitiveness and 
lack of time to complete tests (N=12), technical problems (N=9), lack of utility (N=7) and an 
undesired reminder of their condition (N=4). 
 
Almost 85% of the participants responded they were willing to receive news about improved 
versions of the app in the future. The most frequently requested improvements were a personalized 
crisis plan in the case of relapse (N=71), the possibility to add personal stressful events in the mood 
chart (N=59), greater variety of psychoeducational messages (N=54), interactive mood-chart labels 
(N=38) and new methods to capture mood state without having to completed daily tests (N=33). 
 
Secondary clinical outcomes  
Almost none of the baseline and follow-up measures showed a normal distribution, therefore we 
conducted non-parametric analyses to report and compare the pre-post results. The median WHO-5 
baseline and follow-up scores were 40 (IQR 36) and 48 (IQR 32), respectively.  A Wilcoxon Signed 
Ranks test (Z = -3.88, p <0.001) was significant comparing both scores.  
 
Similarly, the SF-36 showed significant differences between pre and post measures in 6 out of 8 
domains: general health perceptions (Z = -2.92, p <0.01), mental health (Z = -2.81, p <0.01), physical 
role functioning (Z = -3.71, p <0.001), emotional role functioning (Z = -5.12, p <0.001), social 
functioning (Z = -3.37, p <0.001), and bodily pain (Z = -2.92, p <0.05).   
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No statistical significance was found regarding the number of hospitalisations, suicide attempts or 
other secondary clinical outcomes during the past 6 months between completers and non-
completers.    
 
 
Discussion 
The results of this study represent the first attempt to evaluate the feasibility of offering a large-
scale wide-reaching smartphone-based IBP psychoeducation programme for BD. More than 30% of 
the participants continued to use the programme after 6 months. Positive outcomes regarding 
satisfaction and usability were mainly found among completers, whereas high percentages of 
perceived helpfulness, well-being and general health were found among all the participants. The 
data collected in this study provides significant insights into drop-out rate parameters, reasons and 
influencing factors of attrition which could help future platform design strategies and increase the 
chances of patient retention.  
 
OpenSIMPLe is not the first study evaluating an IBP providing psychoeducational content to patients 
suffering from BD at a large scale. Barnes et al. (Barnes et al., 2007) previously developed a web-
based relapse prevention programme (“Recovery Road”) incorporating symptom monitoring and 
feedback, and psychoeducational elements. This consisted of symptom monitoring through 
questionnaires and mood charting with instant feedback on progress or recurrence risks alongside 
specific text-based psychoeducation and Cognitive Behavioural Therapy (CBT) contents. The 
programme was divided into 20 sequential sessions to be delivered in 12 months. An RCT compared 
the active programme with a control treatment containing only contents focused on general health. 
A case management system reminded the users in both groups to login into the sessions with three 
e-mails followed by a telephone call by a research assistant if necessary. No significant differences 
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were found between the intervention  (n=113) and the placebo (n=120) groups regarding the main 
outcome, which was recurrences with or without hospitalization (Barnes et al., 2014). The retention 
rates reported were 75% for the active group and 69% for the control group at 12 months. In 
comparison to OpenSIMPLe which asked subjects to rate their mood and read brief 
psychoeducational messages daily, Recovery Road was less demanding in terms of the daily burden 
as sessions were delivered during specific weeks over a year. Additionally, the reminder e-mail 
system and telephone calls might explain the lower attrition rates in this study.  
 
Using a slightly different approach, Lauder et al. conducted a 12-month randomized trial comparing 
head-to-head the clinical outcomes of two web-based programmes: “Moodswings”, which contained 
psychoeducational material and discussion boards, and “Moodswings Plus” which also included 
elements of CBT (Lauder et al., 2014). The study recruited 156 participants, assigning 78 to each 
programme. They found significant reductions in mood symptoms and improvements in 
functionality, quality of life and medication adherence in both groups. However, the reported 
attrition rate at month 6 was 76% and 81% by month 12, which is greater although not dissimilar to 
the attrition rate observed in our study (66.2%). In a similar manner to our sample, most of the 
dropouts (65%) occurred during the first months of the programme, which suggests that the first 
months of any programme are the most critical in relation to long-term retention.  It should also be 
noted that our programme was delivered through a smartphone-based platform, while the 
aforementioned interventions were web-based, which is also known to influence participants’ 
engagement and expectations (Watts et al., 2013). 
 
Smartphone app retention and engagement is not exclusively an e-mental health problem. It has 
been estimated that in general app retention rates are 36% after 1 month and just 20% after 3 
months of use (Localytics, 2018; Statista, 2016). Regarding health apps, the reported retention is 
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47% after 1 month and just 30% at 3 months (Farago, 2015). Studies specifically evaluating mental 
health apps for other chronic conditions have reported varied attrition rates ranging from 20% to as 
high as 75% (Arean et al., 2016; Donker et al., 2013; Firth and Torous, 2015; Grist et al., 2017).  
 
One of the most likely factors affecting retention in OpenSIMPLe could be its entirely online delivery. 
Screening, enrolment and follow-up were done online without any face-to-face or telephone 
contact. It is possible that the initial intent to give participants the sense of self-management and 
privacy could actually be resulting in less commitment to the programme. This has previously been 
seen by other large-scale clinical trials using a fully remote online approach for depression (Anguera 
et al., 2016; Arean et al., 2016). Interestingly, in one of these studies, which delivered assessments 
and treatments exclusively through mobile devices, Anguera et al. (Anguera et al., 2016) found lower 
adherence among younger participants, which is in line with the findings of our study. This seems 
contradictory, as smartphone usage and ownership are higher among younger age groups (Andone 
et al., 2016; Montag et al., 2015; Poushter, 2016). However, engagement with e-mental health 
interventions in younger participants has already been described as a challenging issue in e-mental 
health interventions. For instance, Nicholas et al. found that young age was a significant predictor of 
attrition in a large 6-month RCT evaluating a web-based psychoeducational programme for BD 
(Nicholas et al., 2010; Proudfoot et al., 2012). Another similarity between this last study and 
OpenSIMPLe is the reasons given by participants for nonadherence. Among them, the fact that the 
programme reminded participants about their illness as well as the burden is especially important to 
consider when delivering more intensive programmes in shorter periods of time.  
 
In contrast to our results, other studies evaluating e-mental health apps have identified several  
factors predictive of engagement other than age, including gender, socioeconomic factors, 
education and illness or symptoms severity (Anguera et al., 2016; Taki et al., 2017; Zeng et al., 2015). 
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In our study, none of the models explored showed a significant association with either manic or 
depressive symptoms in. It is possible that symptomatic or cognitively impaired patients do not have 
the functionality levels required to enrol or reliably use Internet-based programmes. Further 
research is needed to investigate this.  
 
In keeping with the above, it should be considered if smartphone apps can be used in mental health 
as adjunctive stand-alone self-management treatments or as an additional intervention within a 
multicomponent programme with face-to-face assessments and treatments. The majority of 
participants in our study were already receiving some kind of psychological treatment, which might 
have been a factor influencing retention. Regardless of this, any app design should be grounded on 
an evidence-based framework which has to provide a behavioural plan encouraging the users to 
engage with the app (Bakker et al., 2016). Moreover, the balance between duration, frequency and 
engagement requirements to deliver the programme’s contents is one of the most important factors 
that might be considered to ensure retention.  
 
One strategy that has been suggested to encourage app engagement is gamification. This method 
consists in adding elements of the most common video games rewarding and enjoyable mechanisms 
in non-video game contexts such as psychological programs (Brigham, 2015; Miller et al., 2014). In 
parallel, there is also an emergent interest in developing serious games as a potential strategy to 
engage users with e-mental health programmes (Lau et al., 2016; Stapleton, 2004). These are games 
which the main purpose is not entertainment per se but can be education, training or health 
improvement among other aims (Lau et al., 2016; Stapleton, 2004). Following this early evidence and 
users’ suggestions, we implemented a basic gamification module in SIMPLe 1.5. However, the study 
findings suggest this was not perceived as helpful or engaging. Perhaps a more intensive and 
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immersive game experience could have an impact on retention; however, we need to be careful not 
to underestimate the seriousness of their clinical situation and the psychoeducational messages.  
 
In addition to the gamification module, several other features were added to SIMPLe 1.5 based on 
the user-centred design (UCD) approach adopted early in the project (Hidalgo-Mazzei et al., 2015; 
Roth et al., 2014). Nonetheless, our results show that these features were only activated by a small 
percentage of users and the perceived helpfulness was generally low. Although in our smaller 
feasibility study this approach seemed to help attain an acceptable retention rate, the additional 
features didn’t seem to engage a wider nor more diverse target population in this study (Hidalgo-
Mazzei et al., 2016). A potential influencing factor may have been the direct extrapolation of users’ 
feedback from one mental health centre in Spain only, perhaps wrongfully assuming worldwide 
applicability. While there are several successful examples of adopting this approach (Chiauzzi et al., 
2015; Vilardaga et al., 2018), there are other studies reporting similar acceptability and retention 
rates using a top-down platform development (Biagianti et al., 2017). Nonetheless, we believe that 
this iterative process, if comprehensive and pragmatic enough, could provide essential information 
about users’ preferences as well as the optimal balance between convenience and burden, which 
could ultimately increase satisfaction rates and potential favourable clinical outcomes.  
 
Finally, we acknowledge that the role of a feasibility implementation study in parallel to an efficacy 
trial in the context of smartphone app validation might be a matter of debate. As the ultimate aim is 
to make e-mental health IBPs available to patients, we believe these kinds of implementation 
feasibility studies are an important step of the process. Bipolar illness may be one of the best 
disorder candidates for this type of approaches (Grande et al., 2016; Vieta et al., 2018), given, on the 
one hand, the severity and highly recurrent profile of the disease, and on the other hand the ability 
of many of these patients to benefit from psychoeducative interventions. 
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Limitations 
There are several methodological and practical limitations of this work that must be noted and 
generalizing results should be done with caution.  
 
First, the screening, baseline and follow-up measures were administered using exclusively self-
reported online methods which impeded reaching out back participants who dropped out to collect 
reasons for attrition or further comments about their experience with the programme. Furthermore, 
the accuracy and reliability of the information provided could not be verified, and this may have 
influenced the sample included and the secondary outcome results. For instance, the MDQ 
employed as a screening method has good sensitivity but low specificity, which could have resulted 
in the inclusion of participants who do not have a professional diagnosis of BD, but instead of other 
conditions such as borderline personality disorder (Zimmerman et al., 2011). However, this an issue 
also present in face-to-face interviews on routine clinical care (Ruggero et al., 2010; Zimmerman, 
2016). Furthermore, clinical information such as illness years, previous episodes, comorbidities, 
hospital admissions and treatments received also relied only on self-report. Nevertheless, these data 
were similar to other clinical studies using face-to-face validated assessments and international 
treatment patterns. For example, there were high rates of antidepressants prescription in our 
sample of participants which was somewhat similar to other larger international studies (Samalin et 
al., 2016). This still seems contradictory taking into account the most recent treatment guidelines 
and consensus recommendations for BD (Goodwin et al., 2016; Pacchiarotti et al., 2013). The only 
exception on the similarity with other studies including patients with BD was the number of previous 
mood episodes, which was higher than expected; this could be a consequence of participants 
identifying reactive emotional fluctuations or subsyndromal symptoms with relapses. It also worth 
mentioning that our study had a low number of exclusion criteria in order to replicate an open 
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platform in a real world-setting of diverse participants. We tried to partially minimize this by 
assessing and reviewing, both with conditional algorithms and manual review, the consistency of 
every participant’s screening and baseline responses.  
 
Secondly, there was no alternative intervention or control group which could discriminate against a 
potential placebo effect in our study as it was not designed or aimed to demonstrate efficacy. 
Thirdly, we performed analyses to compare pre-post primary and secondary outcomes in the whole 
sample as well as between completers and non-completers. Although primary outcomes regarding 
satisfaction and usability were positive, it should be noted that this was predominantly among 
completers who might be more likely to report positive outcomes. Furthermore, even though some 
positive secondary clinical outcomes were found, these results should be taken with caution as most 
of them were based only in pre-post measures. 
 
Finally, the attrition rate could limit the generalizability of the results as only about a third of the 
sample used the app for the entire duration of the programme and only about a half replied to the 
follow-up questionnaire. This resulted in skewed data, which we attempted to mitigate by 
implementing appropriate statistical methods. Further studies with larger samples could address this 
issue. Moreover, as it has already been demonstrated, passive behaviour information (i.e. without 
users input) captured from the smartphone usage and sensors could enhance the precision of 
clinical algorithms and could represent a paradigm shift in mood tracking methods (Faurholt-Jepsen 
et al., 2018, 2015; Hidalgo-Mazzei et al., 2018). The next version of SIMPLe (i.e. SIMPLe+) 
incorporates this technology based on smartphone usage patterns and sleep tracking capabilities to 
enable a better personalization of psychoeducational messages and avoid the burden of answering 
daily tests, thus addressing one of the main reasons for drop-out given by participants.  
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Regarding the limitations of the app itself, it was only available in Spanish which restricted the access 
to potential participants with different languages.  
 
Conclusion 
The attrition rates of our implementation feasibility study delivering a large-scale psychoeducational 
programme for BD through smartphones were significant. We found positive outcomes regarding 
satisfaction and usability predominantly among completers, as well as perceived helpfulness and 
reported benefits to well-being and general health of all participants. The only variable significantly 
associated with retention was older age. In addition to proving efficacy, future studies should 
explore the optimal strategy to balance frequency, intensity and duration of these kinds of e-mental 
health programmes as well as to better understand user retention and engagement factors. 
 
Upon overcoming the retentions issues and demonstrating efficacy, these platforms could become 
extremely cost-efficient tools for delivering psychoeducational contents to patients with BD globally 
due to the remarkably low set-up and maintenance costs.  
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Figure 1. Study process flowchart 
 
MDQ= Mood disorders questionnaire.  
 
Figure 1. The flowchart describes the number of subjects who visited the project´s website and the 
number of users who actually viewed the study web-page alongside the devices from which they 
accessed it. Subsequently the flowchart describes those users who went on to read the information 
about the study and conditions to participate. Reasons reported by users who didn´t want to 
participate in the study are also listed. Finally, potential participants who were excluded and their 
reasons are described, as well as the number of participants included in the study and those who 
responded the 6-month follow-up questionnaire.  
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 *Figure 2. OpenSIMPLe study 6-months users retention  
 
Figure 2. The figure shows the percentage of active users retention in each of 6 months of the study. 
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Figure 3. OpenSIMPLe programme components perceived 
helpfulness 
 
Figure 3. The bars denote the percentage of perceived helpfulness of each component of the 
programme by the users who responded to the follow-up questionnaire. Right areas of the bars 
shows stronger agreement that the component was helpful while left areas stronger disagreement.   
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Table 1. Baseline sociodemographic characteristics (N=201) 
 Mean SD 
Age 36.59 11.0 
 N Percentage 
Gender 
Male 74 36.8 
Female 127 63.2 
Ethnicity 
Latin-american 121 60.5 
Caucasian 77 38.5 
African 1 0.5 
Asian 1 0.5 
Educational level 
Low 8 4.0 
Medium 67 33.3 
High 126 62.7 
Marital status 
Single 93 46.2 
Married/Cohabitating 67 33.3 
Divorced/Separated 32 15.9 
Employment status 
Student 32 15.9 
Employed 84 41.8 
Unemployed 38 18.9 
Permanent disability leave 22 10.9 
Temporary disability leave 20 10 
Retired 5 2.5 
Housing status 
Home owner/renter 106 52.8 
Shared home 90 44.8 
Institution/residence 5 2.4 
SD = Standard deviation 
Table 1. The table details the baseline sociodemographic characteristics of the participants.  
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Table 2. Baseline clinical characteristics and treatments 
(N=201) 
 N Percentage 
Comorbidity 
Medical comorbidities 123 61.2 
Anxiety disorders 75 37.3 
Personality disorders 41 20.4 
Substance use disorders (SUD) 26 12.9 
Post-traumatic stress disorder (PTSD) 11 5.5 
Any psychiatric comorbidity 123 61.2 
Family History of psychiatric disorder 
None 50 24.9 
First degree 73 36.3 
Second degree 44 21.9 
Third degree 34 16.9 
Current pharmacological and non-pharmacological treatments 
Mood stabilizers 156 77.6 
Antipsychotics 129 64.1 
Antidepressants 98 48.7 
Benzodiazepines 97 48.2 
Electroconvulsive therapy (ECT) 1 0.5 
Psychological treatment 143 71.1 
Previous non-pharmacological treatments 
Psychological treatment 178 88.5 
Electroconvulsive therapy (ECT) 10 5 
 Mean SD 
Illness course 
Manic/Hypomanic episodes 6.9 3.3 
Depressive episodes 6.2 3.6 
Total episodes 13.1 5.9 
Age of onset (years) 27.9 9.6 
Illness years 7.9 8.1 
Episode density 0.8 1.2 
Previous hospital admissions due to an episode 1.3 1.9 
Previous suicide attempts 1.2 1.7 
SD = Standard deviation 
 
Table 2. The table details the baseline clinical characteristics and treatments of the participants.  
